Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
35.93
+0.12 (0.34%)
At close: Sep 28, 2026, 4:00 PM EDT
35.61
-0.32 (-0.89%)
Pre-market: Sep 29, 2026, 5:31 AM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $1.1 billion as of September 28, 2026. Its market cap has increased by 66.62% in one year.
Market Cap
1.10B
Enterprise Value
867.49M
1-Year Change
66.62%
Ranking
Category
Stock Price
$35.93
ChartMarket Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $1.10B, an increase of 792.02%. That is a compound annual growth rate of 35.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 1.10B | -3.33% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 4.70B |
| Veracyte | 3.65B |
| CareDx | 3.29B |
| GeneDx Holdings | 2.64B |
| NeoGenomics | 2.48B |
| Personalis | 1.76B |
| Freenome | 1.72B |
| OPKO Health | 1.22B |